237 related articles for article (PubMed ID: 25936371)
1. Establishment of an interleukin-1β-induced inflammation-activated endothelial cell-smooth muscle cell-mononuclear cell co-culture model and evaluation of the anti-inflammatory effects of tanshinone IIA on atherosclerosis.
Li Y; Guo Y; Chen Y; Wang Y; You Y; Yang Q; Weng X; Li Q; Zhu X; Zhou B; Liu X; Gong Z; Zhang R
Mol Med Rep; 2015 Aug; 12(2):1665-76. PubMed ID: 25936371
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution.
Schmitt MM; Fraemohs L; Hackeng TM; Weber C; Koenen RR
Atherosclerosis; 2014 Jun; 234(2):254-64. PubMed ID: 24704627
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of tanshinone IIA on Propionibacterium acnes-induced inflammation in vitro.
Li Y; Zhou Y
Dermatol Ther; 2018 Nov; 31(6):e12716. PubMed ID: 30246913
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms.
Alexander MR; Murgai M; Moehle CW; Owens GK
Physiol Genomics; 2012 Apr; 44(7):417-29. PubMed ID: 22318995
[TBL] [Abstract][Full Text] [Related]
6. Digitoxin elicits anti-inflammatory and vasoprotective properties in endothelial cells: Therapeutic implications for the treatment of atherosclerosis?
Jagielska J; Salguero G; Schieffer B; Bavendiek U
Atherosclerosis; 2009 Oct; 206(2):390-6. PubMed ID: 19446813
[TBL] [Abstract][Full Text] [Related]
7. A novel in vitro model for the study of plaque development in atherosclerosis.
Dorweiler B; Torzewski M; Dahm M; Ochsenhirt V; Lehr HA; Lackner KJ; Vahl CF
Thromb Haemost; 2006 Jan; 95(1):182-9. PubMed ID: 16543978
[TBL] [Abstract][Full Text] [Related]
8. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.
Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS
Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094
[TBL] [Abstract][Full Text] [Related]
10. Notoginsenoside R1 inhibits oxidized low-density lipoprotein induced inflammatory cytokines production in human endothelial EA.hy926 cells.
Su P; Du S; Li H; Li Z; Xin W; Zhang W
Eur J Pharmacol; 2016 Jan; 770():9-15. PubMed ID: 26607460
[TBL] [Abstract][Full Text] [Related]
11. H
Monti M; Terzuoli E; Ziche M; Morbidelli L
Pharmacol Res; 2016 Nov; 113(Pt A):426-437. PubMed ID: 27650753
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory and Apoptotic Regulatory Activity of Tanshinone IIA in Helicobacter pylori-Infected Cells.
Chen GY; Shu YC; Chuang DY; Wang YC
Am J Chin Med; 2016; 44(6):1187-1206. PubMed ID: 27627918
[TBL] [Abstract][Full Text] [Related]
13. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation.
Fukuda K; Matsumura T; Senokuchi T; Ishii N; Kinoshita H; Yamada S; Murakami S; Nakao S; Motoshima H; Kondo T; Kukidome D; Kawasaki S; Kawada T; Nishikawa T; Araki E
Biochem Biophys Res Commun; 2015 Jan; 457(1):23-30. PubMed ID: 25529449
[TBL] [Abstract][Full Text] [Related]
14. 2-hydroxy-4'-methoxychalcone inhibits proliferation and inflammation of human aortic smooth muscle cells by increasing the expression of peroxisome proliferator-activated receptor gamma.
Liu CS; Chang CC; Du YC; Chang FR; Wu YC; Chang WC; Hsieh TJ
J Cardiovasc Pharmacol; 2012 Apr; 59(4):339-51. PubMed ID: 22157260
[TBL] [Abstract][Full Text] [Related]
15. Water filtration rate and infiltration/accumulation of low density lipoproteins in 3 different modes of endothelial/smooth muscle cell co-cultures.
Ding Z; Fan Y; Deng X
Sci China C Life Sci; 2009 Nov; 52(11):1023-9. PubMed ID: 19937200
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
[TBL] [Abstract][Full Text] [Related]
18. Pressure alters endothelial effects upon vascular smooth muscle cells by decreasing smooth muscle cell proliferation and increasing smooth muscle cell apoptosis.
Vouyouka AG; Jiang Y; Basson MD
Surgery; 2004 Aug; 136(2):282-90. PubMed ID: 15300192
[TBL] [Abstract][Full Text] [Related]
19. Anti-atherosclerotic effect of Longxuetongluo Capsule in high cholesterol diet induced atherosclerosis model rats.
Zhou JM; Wang HM; Lv YZ; Wang ZZ; Xiao W
Biomed Pharmacother; 2018 Jan; 97():793-801. PubMed ID: 29112932
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
